Journal
FRONTIERS IN PHARMACOLOGY
Volume 6, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2015.00061
Keywords
pharmacogenomics; whole genome sequencing; pharmacogenomics biomarkers; genome-wide association studies; genotype; pesonalized medicine
Categories
Funding
- National (eMoDiA) [SigmaY N11_0415]
- European Commission (RD-Connect) [FP7-305444]
Ask authors/readers for more resources
Pharmacogenomics aims to shed light on the role of genes and genomic variants in clinical treatment response. Although, several drug gene relationships are characterized to date, many challenges still remain toward the application of pharmacogenomics in the clinic; clinical guidelines for pharmacogenomic testing are still in their infancy, whereas the emerging high throughput genotyping technologies produce a tsunami of new findings. Herein, the potential of whole genome sequencing on pharmacogenomics research and clinical application are highlighted.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available